Literature DB >> 20703045

Diabetic macular edema.

Francesco Bandello, Maurizio Battaglia Parodi, Paolo Lanzetta, Anat Loewenstein, Pascale Massin, Francesca Menchini, Daniele Veritti.   

Abstract

Diabetic macular edema (DME), defined as a retinal thickening involving or approaching the center of the macula, represents the most common cause of vision loss in patients affected by diabetes mellitus. In the last few years, many diagnostic tools have been proven useful in the detection and the monitoring of the features characterizing DME. On the other hand, several therapeutic approaches can now be proposed on the basis of the DME-specific characteristics. The aim of the present chapter is to thoroughly delineate the clinical and morpho functional characteristics of DME and its current treatment perspectives. The pathogenesis and the course of DME require a complex approach with multidisciplinary intervention both at the systemic and local levels. 2010 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20703045     DOI: 10.1159/000320075

Source DB:  PubMed          Journal:  Dev Ophthalmol        ISSN: 0250-3751


  9 in total

1.  [Navigated focal retinal laser therapy using the NAVILAS® system for diabetic macula edema].

Authors:  M Kernt; R Cheuteu; R G Liegl; F Seidensticker; S Cserhati; C Hirneiss; C Haritoglou; A Kampik; M Ulbig; A S Neubauer
Journal:  Ophthalmologe       Date:  2012-07       Impact factor: 1.059

2.  Visual and anatomical outcomes following vitrectomy for complications of diabetic retinopathy: the DRIVE UK study.

Authors:  B Gupta; S Sivaprasad; R Wong; A Laidlaw; T L Jackson; D McHugh; T H Williamson
Journal:  Eye (Lond)       Date:  2012-01-06       Impact factor: 3.775

3.  Diabetic Retinopathy-Update on Prevention Techniques, Present Therapies, and New Leads.

Authors:  Lauren M Marozas; Patrice E Fort
Journal:  US Ophthalmic Rev       Date:  2014

Review 4.  Oxidative stress and epigenetic modifications in the pathogenesis of diabetic retinopathy.

Authors:  Renu A Kowluru; Anjan Kowluru; Manish Mishra; Binit Kumar
Journal:  Prog Retin Eye Res       Date:  2015-05-12       Impact factor: 21.198

5.  Ranibizumab in the treatment of patients with visual impairment due to diabetic macular edema.

Authors:  Francesco Bandello; Umberto De Benedetto; Karl Anders Knutsson; Maurizio Battaglia Parodi; Maria Lucia Cascavilla; Pierluigi Iacono
Journal:  Clin Ophthalmol       Date:  2011-09-14

6.  Ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema: a meta-analysis of randomized controlled trials.

Authors:  Guohai Chen; Wensheng Li; Radouil Tzekov; Fangzheng Jiang; Sihong Mao; Yuhua Tong
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

7.  Effect of thiamine pyrophosphate on retinopathy induced by hyperglycemia in rats: A biochemical and pathological evaluation.

Authors:  Emine Cinici; Ibrahim Ahiskali; Nihal Cetin; Bahadir Suleyman; Osman Kukula; Durdu Altuner; Abdulkadir Coban; Hilal Balta; Mehmet Kuzucu; Halis Suleyman
Journal:  Indian J Ophthalmol       Date:  2016-06       Impact factor: 1.848

Review 8.  Ocular Complications of Diabetes and Therapeutic Approaches.

Authors:  Victoria J Vieira-Potter; Dimitrios Karamichos; Darren J Lee
Journal:  Biomed Res Int       Date:  2016-03-28       Impact factor: 3.411

9.  Effect of intravitreal dexamethasone solution on the reduction of macular thickness in pseudophakic diabetic patients in a public hospital in Brazil: a randomized clinical trial.

Authors:  Andre Luis A Fonseca; Heitor Panetta; Mauricio A Nascimento; Rodrigo Pessoa C Lira; Carlos Eduardo L Arieta
Journal:  Clin Ophthalmol       Date:  2019-08-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.